Year: 2023

Global Clinical Trial Software Market Size to Reach USD 5,110.94 Million in 2032 | Emergen Research

Written by Customer Service on October 18, 2023. Posted in Mergers And Acquisitions.

Rising number of clinical trials to discover novel drugs and increasing need to accelerate drug development process and reduce R&D costs are some key factors driving clinical trial software market reveue growth Vancouver, Oct. 18, 2023 (GLOBE NEWSWIRE) — The global clinical trial software market size reached USD 900.3 Million in 2020 and is expected to register a revenue CAGR of 15.6%, during the forecast period, according to latest analysis by Emergen Research. Rising number of clinical trials to discover novel drugs and increasing need to accelerate drug development process and reduce R&D costs are some key factors expected to continue to drive global clinical trial software market revenue growth over the forecast period. Research and development is an important constituent for effective drug and product development. Rising...

Candel Therapeutics Announces Nature Publication Showing Extended Survival Associated with Immune Activation in Patients with Recurrent High-Grade Glioma Treated with CAN-3110

Written by Customer Service on October 18, 2023. Posted in Public Companies.

CAN-3110 is a first-in-class herpes simplex virus-1 oncolytic immunotherapy candidate with dual activity for oncolysis and immune activation in a single therapeutic In a first-in-human clinical trial of CAN-3110 in recurrent high-grade glioma, CAN-3110 was well tolerated and treatment was associate with improved survival Positive HSV-1 serology, before or after CAN-3110 injection, was a predictor of response and was associated with improved survival Increased infiltrating immune cells in the tumor microenvironment and expansion of the T cell repertoire after treatment were associated with improved survivalNEEDHAM, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (the Company or Candel) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing viral immunotherapies to help patients fight...

Global Hyperscale Computing Market Size to Reach USD 2,729.56 Billion in 2032 | Emergen Research

Written by Customer Service on October 18, 2023. Posted in Mergers And Acquisitions.

Rising focus towards high performance computing and increasing need to reduce capital and operational expenditures are some key factors driving hyperscale computing market growth Vancouver, Oct. 18, 2023 (GLOBE NEWSWIRE) — The global hyperscale computing market size reached USD 149.07 Billion in 2020 and is expected to register a revenue CAGR of 27.4% during the forecast period, according to latest analysis by Emergen Research. Rising preference for high performance computing and technologies is a major factor expected to drive global hyperscale computing market revenue growth to a significant extent over the forecast period. Need for processing data at high speed and with high accuracy and precision continues to drive steady adoption of high performance computing solutions across various verticals and sectors globally. Ability...

Hormonal Contraceptive Market to Surpass 24.2 Billion by 2030 Drives Due to Changing Demographics

Written by Customer Service on October 18, 2023. Posted in Mergers And Acquisitions.

SkyQuest projects that the hormonal contraceptive market will attain a USD 24.2 billion value by 2030, with a CAGR of 4.31% over the forecast period (2023-2030). Increasing awareness about family planning and women’s health drives the hormonal contraceptive market, especially in developing regions. As more women delay childbirth and seek reliable contraception, the market experiences growth. Westford, USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, ongoing research and innovation in hormonal contraceptive methods, such as patches, implants, and injections, propel market expansion. Enhanced effectiveness, convenience, and reduced side effects attract users, fostering hormonal contraceptive market demand. Browse In-Depth TOC on the “Hormonal Contraceptive Market” Pages – 157 Tables –...

Global Fc Fusion Protein Market Size to Reach USD 88.68 Billion in 2032 | Emergen Research

Written by Customer Service on October 18, 2023. Posted in Mergers And Acquisitions.

Increasing usage of Fc fusion proteins for in vivo and in vitro research and increasing use as drugs are some key factors driving global Fc fusion protein market revenue growth Vancouver, Oct. 18, 2023 (GLOBE NEWSWIRE) — Current Market Scenario: The global Fc fusion protein market size reached USD 26.97 Billion in 2020 and is expected to register a significantly robust revenue CAGR during the forecast period, according to latest analysis by Emergen Research. Drivers: Some key factors expected to drive market revenue growth over the forecast period include increasing demand for Fc fusion proteins in non-clinical applications and rising prevalence of diabetes globally. Diabetes affects around 422 million people globally, the majority of whom live in low- and middle-income countries, and diabetes is directly responsible for 1.6 million...

Global Food Enzymes Market Size to Reach USD 4,194.46 Million in 2032 | Emergen Research

Written by Customer Service on October 18, 2023. Posted in Mergers And Acquisitions.

Increasing demand for covenience food and growing health consciousness amongst consumers are significant factor driving global food enzymes market revenue growth Vancouver, Oct. 18, 2023 (GLOBE NEWSWIRE) — Current Market Scenario (Market estimates) The global Food Enzymes Market size was USD 2,058.0 Million in 2020. Rising demand for food enzymes from the food & beverage industry and increasing health awareness among an increasing number of consumers is driving global food enzymes market revenue growth to a significant extent. Also, market players are focusing on producing enzymes for which large scale production is not possible, thereby offering customers access to a wider variety of products. One such enzyme is amylase, which is used to extend the freshness of breads. Drivers: Increasing demand for convenience food Convenience...

Aegion Announces Acquisition of AP Civil Solutions, LLC

Written by Customer Service on October 18, 2023. Posted in Mergers And Acquisitions.

The North American Leader in Technology-Enabled Water Solutions Continues Expansion of Utility Services ST. LOUIS, Oct. 18, 2023 (GLOBE NEWSWIRE) — Aegion Corporation, the leading provider of infrastructure maintenance, rehabilitation and technology-enabled water solutions, today announced the acquisition of AP Civil Solutions, LLC, a full-service water and wastewater maintenance company located in central Florida. AP Civil Solutions will now operate as part of Insituform, an Aegion portfolio company. Founded in 2016 by Anthony Bosco, AP Civil found its niche offering pipe rehabilitation services for underground sanitary sewer, storm sewer and potable water pipes in Central Florida. Today, AP Civil has grown to become a premier service provider for municipal and Homeowners Association (HOA) clients across Florida. “We are excited...

Global Nutrigenomics Market Size to Reach USD 2,351.33 Million in 2032 | Emergen Research

Written by Customer Service on October 18, 2023. Posted in Mergers And Acquisitions.

Rising prevalence of obesity and cardiovascular diseases and increasing demand for personalized nutrition among athletes are key factors driving market revenue growth Vancouver, Oct. 18, 2023 (GLOBE NEWSWIRE) — The global nutrigenomics market size is expected to reach USD 2,351.33 Million in 2032 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Market revenue growth is primarily driven by rising prevalence of obesity and cardiovascular diseases due to sedentary lifestyle and changing food habits. According to the World Health Organization (WHO), Cardiovascular Diseases (CVDs) are the leading cause of deaths globally. As estimated 17.9 million people died from cardiovascular diseases in 2019, which represents almost 32% of all global deaths. More than four out of five cardiovascular...

Dresner Partners Advised The Waldorf Center for Plastic Surgery and The Spa at the Waldorf Center on Its Sale to Forefront Dermatology

Written by Customer Service on October 18, 2023. Posted in Mergers And Acquisitions.

CHICAGO, Oct. 18, 2023 (GLOBE NEWSWIRE) — Dresner Partners, an award-winning, FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised The Waldorf Center for Plastic Surgery, P.C. and The Spa at the Waldorf Center, Inc. (collectively “Waldorf”) on its sale to Forefront Dermatology®. Terms of the transaction were not disclosed. The Waldorf Center, founded in 1993 by board-certified plastic surgeon Kathleen Waldorf, M.D., F.A.C.S., is dedicated to providing the highest level of comprehensive cosmetic and reconstructive plastic surgery care and spa services in Beaverton and Portland, Oregon. The Waldorf Center recently expanded into Vancouver, Washington through the acquisition of The Workman Center for Beautiful Skin and Bodies. The Waldorf Center specializes in a wide...

CORRECTION – Sirios announces a Private Placement

Written by Customer Service on October 18, 2023. Posted in Public Companies.

In a release issued under the same headline on Tuesday, October 17th by Sirios Resources Inc. (TSX-V: SOI), please note that in the second sentence of the first paragraph, the maximum amount of Common Shares issued as “flow-through shares” should be 3,125,000, not 8,125,000. The corrected release follows: Not for distribution to United States newswire services or for dissemination in the United States MONTREAL, Oct. 18, 2023 (GLOBE NEWSWIRE) — SIRIOS RESOURCES INC. (TSX-V: SOI) (the “Corporation”) announces its intention to complete a non-brokered private placement with investors relying on a prospectus exemption pursuant to Regulation 45-106 respecting Prospectus Exemptions for gross proceeds of up to $500,000 (the “Offering”). This Offering consists of the issuance of a maximum of 5,000,000 common shares of the Corporation (the “Common...

Year: 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals